No Data
Cellectar Biosciences: Delay in Filing 10-Q Is a Result of Company's Need to Restate Certain Previously Filed Fincl Statements >CLRB
Cellectar Biosciences: Notice Indicated Co Isn't in Compliance With Report Filing Requirement in Nasdaq Listing Rule as a Result of Delay in Filing Form 10-Q >CLRB
Express News | Cellectar to Restate Previously Issued Financial Statements – Company Announces Receipt of Expected Delinquency Notification Letter From Nasdaq
Strong Buy Recommendation for Cellectar Biosciences on Positive Phase 2b Results and Solid Financials
Express News | Cellectar: To Re-Evaluate Accounting Treatment for Warrants Issued in Financing Completed in Oct. 2022
Express News | Cellectar Biosciences: Unable to File Quarterly Report for Quarter Ended June 30 by August 14